Search
for
Sort by
Research 301–330 of 1000+
- Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
- The Use of 308-nm Excimer Laser Therapy in Alopecia Areata and Primary Cicatricial Alopecia: A Systematic Review
- 153 Effectiveness of OR-101, a next generation highly selective JAK3 inhibitor, in a humanized murine model of alopecia areata
- 022 Exploring the potential of the novel IFNγ aptamer TAGX-0003 as a treatment for alopeciaareata in pre-clinical models
- Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study
- Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata
- New Modalities in the Treatment of Refractory Alopecia Areata
- A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis
- Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth
- Tru9I Variant as a Novel Genetic Marker for Vitamin D Deficiency in Alopecia Areata
- Evaluation of the efficacy of topical metformin 10% and 20% versus topical potent steroid in the treatment of patients with alopecia areata
- Reversal of alopecia areata, osteoporosis follow treatment with activation of Tgr5 in mice
- Immune therapies for alopecia areata: evidence and new perspectives
- AIRE Deficiency Leads to the Development of Alopecia Areata‒Like Lesions in Mice
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Alopecia areata susceptibility variant in MHC region impacts expressions of genes contributing to hair keratinization and is involved in hair loss
- Alopecia areata: What’s new in the epidemiology, comorbidities, and pathogenesis?
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Case report: Sequential therapy with dupilumab and baricitinib for severe alopecia areata with atopic dermatitis in children
- JAK Inhibitors for Treatment of Alopecia Areata
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Alopecia Areata: A Review of the Role of Oxidative Stress, Possible Biomarkers, and Potential Novel Therapeutic Approaches
- Cancer risk in patients with alopecia areata: a nationwide population‐based matched cohort study
- Dietary Habits in Japanese Patients with Alopecia Areata
- Efficacy of Local and Whole‐Body Phototherapy for the Treatment of Various Types of Alopecia Areata
- Correlation between increased total serum IgE levels and clinical features in alopecia areata patients
- Clinical Efficacy and Safety of Baricitinib in Patients With Alopecia Areata in Korea
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience